Institutional Ownership Silverback Therapeutics, Inc. (SBTX)
This table provides information about the institutional ownership of Silverback Therapeutics, Inc. (SBTX). We have compiled data on the 205 institutions that hold shares in the stock, with a total of 84.3 Million shares, which have been reported (via 13F filing form) to have a value of $0.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
10,860,977
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
9,724,508
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 7.51%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
8,288,510
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 10.31%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,084,339
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 53.65%
|
|
Sr One Capital Management, LP
|
Aug 14, 2025 Q2 2025 |
4,012,903
shares
|
$0
0.0% of portfolio
|
Q1 2023
Added 33.33%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
3,825,793
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 2.47%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,262,673
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 6.47%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
2,242,176
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 179.82%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,194,493
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 8.04%
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
1,828,755
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 1.55%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,728,000
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
Southpoint Capital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,709,069
shares
|
$0
0.0% of portfolio
|
Q2 2025
New holding
|
|
Abrdn PLC
|
Jul 24, 2025 Q2 2025 |
1,502,575
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 49.86%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,464,312
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 103.96%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,433,187
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 987.59%
|
|
Octagon Capital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,350,000
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 116.0%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,342,387
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 6.5%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
1,303,399
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 0.74%
|
|
Rubric Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,294,878
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 25.83%
|
|
Cormorant Asset Management, LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,100,000
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 31.25%
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
936,729
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 15.84%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
878,157
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 8.81%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
866,935
shares
|
$0
0.0% of portfolio
|
Q2 2025
Added 46.64%
|
|
Nextech Invest, Ltd.
Zurich, V8 |
Aug 14, 2025 Q2 2025 |
741,729
shares
|
$0
2.45% of portfolio
|
Q2 2025
Reduced 20.82%
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
673,370
shares
|
$0
0.0% of portfolio
|
Q2 2025
Reduced 4.73%
|